Published in

Elsevier, Vaccine, 23(35), p. 3041-3049, 2017

DOI: 10.1016/j.vaccine.2017.04.058

Links

Tools

Export citation

Search in Google Scholar

Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO